Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAT2A | P31153 | 1/20 | 0.31 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7911441 | 0.85 | MAT2A (0.31) | MAT2ANOTUMLMNA | |
| SCHEMBL3211179 | 0.77 | NOTUM (0.35) | MAT2ANOTUMLMNA | |
| SCHEMBL8801367 | 0.76 | DAO (0.37) | MAT2ANOTUMLMNA | |
| SCHEMBL8305450 | 0.76 | ALDH1A1 (0.35) | MAT2ANOTUMLMNA | |
| SCHEMBL7991493 | 0.76 | ADORA2A (0.33) | MAT2ANOTUMLMNA | |
| SCHEMBL8801755 | 0.74 | LMNA (0.33) | LMNA | |
| SCHEMBL3934691 | 0.73 | MTNR1B (0.32) | — | |
| SCHEMBL6497619 | 0.70 | PDE4A (0.35) | LMNA | |
| SCHEMBL8621897 | 0.70 | — | — | |
| SCHEMBL5407633 | 0.69 | MEN1 (0.34) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3010893-B1 | ARYLSULFIDE AND ARYLSULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2019-10-02 | — | — | EP | disclosed |
| US-9981940-B2 | Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2018-05-29 | — | — | US | disclosed |
| US-20160145235-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2016-05-26 | — | — | US | disclosed |
| EP-3010893-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | Bayer CropScience Aktiengesellschaft (DE) | 2016-04-27 | — | — | EP | disclosed |
| WO-2014202510-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | BAYER CROPSCIENCE AG (DE) | 2014-12-24 | — | — | WO | disclosed |
| EP-0534266-B1 | Sulfonylaminocarbonyltriazolones with two through oxygen bonded substituents | BAYER AG (DE) | 1997-05-28 | — | — | EP | disclosed |
| US-5631380-A | CHEMICAL INTERMEDIATES AND HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-05-20 | — | — | US | disclosed |
| US-5554761-A | Herbicidal sulphonylaminocarbonyltriazolinones having two substituents bonded via oxygen | BAYER AKTIENGESELLSCHAFT (DE) | 1996-09-10 | — | — | US | disclosed |
| US-5488028-A | PLANT GROWTH REGULATORS AND ANTIGROWTH AGENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1996-01-30 | — | — | US | disclosed |
| US-5300480-A | Pre- and postemergent | BAYER AKTIENGESELLSCHAFT (DE) | 1994-04-05 | — | — | US | disclosed |
| EP-0534266-A1 | Sulfonylaminocarbonyltriazolones with two through oxygen bonded substituents | BAYER AG (DE) | 1993-03-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160145235-A1 | ARYL SULFIDE DERIVATIVES AND ARYL SULFOXIDE DERIVATIVES AS ACARICIDES AND INSECTICIDES | ARSA, SQOR, AHR | MAT2A 335/4885NOTUM 505/4885LMNA 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.